Shionogi invested in Restore Vision Inc., a startup developing visual restoration gene therapy using "Chimeric Rhodopsin," a protein-based optical sensor to treat retinal disorders causing blindness where no effective treatments exist. The technology aims to alleviate patient hardships and caregiver burdens.
Source: phys. Original: https://phys.org/news/2026-04-unveil-ai-driven-coral-reef.html
